SAFE Score Outperforms Other Tools in Predicting Cirrhosis for Steatotic Liver Disease Patients

A study published in JAMA Internal Medicine found that the steatosis-associated fibrosis estimator (SAFE) score is the most effective tool for predicting cirrhosis in patients with steatotic liver disease. This research could have implications for healthcare practices in Iran, where liver diseases are a growing concern. Improved diagnostic tools are crucial for managing public health in the country.

🏷️ Entities Mentioned